4 results
hematology algorithm cancer diagnosis malignancy vte differentiation essential et syndrome
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... anticoagulants (DOACs ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
►
 Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
DOAC, direct oral ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Differentiation Syndrome in APML ... Triggers: ATRA treatment ... fluid overload, PCC ... #diagnosis #management ... #hematology #oncology
Essential Thrombocythemia (ET) ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Essential Thrombocythemia ... transformation into MDS or AML ... Hydroxyurea + anticoagulation ... #Essential #Thrombocythemia ... #diagnosis #management
No results found for "PLC hepatology treatment management criticalcare anticoagulation oncology apml doac thrombocythemia"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PLC #hepatology #treatment #management #criticalcare #anticoagulation #oncology #apml #doac #thrombocythemia